Bioscan Inc Details

Bioscan Inc

Company Profile:

Bioscan Inc is a developer and supplier of advanced molecular imaging tools for Preclinical and clinical trial applications. The company has launched an outstanding dual modality SPECT/CT scanner: NanoSPECT/CT and the first sub-millimeter PET/CT scanner: NanoPET/CT to enable non invasive imaging of animals as small as mice with the same visual acuity as provided by human scanners, thus enabling translational research across species.

Bioscan's product portfolio is oriented towards providing complete solutions for biomarker imaging, including tracer synthesis, quality control and translational tomographic imaging. Its multi modality molecular imagers are engineered to enable the discovery of new targeted biomarkers, to accelerate preclinical research, and to facilitate the translation of results from animal models to human applications.

Previous Clients:
Schering Pharma
AstraZeneca International
Abbott Laboratories
CellCyte Genetics
Oxford University
Vanderbilt University
Columbia University
University of Massachusetts
Genentech Inc
National Cancer Center Research Institute-Japan
Biopolis Singapore
University of London
National Cancer Institute- the Netherlands
Life Sciences Facilities of Philips Molecular Research
Henry Ford Hospital
Chang Gung Memorial Hospital - Taiwan
Erasmus University

Key Products:

Bioscan recently introduced two new molecular scanners for small animal imaging: the NanoPET/CT and the NanoSPECT/CT. With over thirty global installations in pharma and biotech companies and core academic facilities, these dual modality systems are dramatically altering the way researchers use animal models to study mechanisms of disease, its progression, and its response to a therapeutic intervention.

NanoPET/CT and NanoSPECT/CT features very high system sensitivity and sub millimeter resolution, enabling fast, dynamic scans, capabilities never before efficiently achieved on a Preclinical imaging systems. This is particularly helpful for monitoring and accurate quantification of organ uptake and physiological changes with high temporal sampling for Preclinical research in oncology, cardiology and neurology.

Website:
www.bioscan.com